28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 6000 - 6200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1015 | Premature Menopause | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1019 | Amenorrhea | active | 2021-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1031 | Acute Pharyngitis | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1033 | Acute Pharyngitis | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1034 | Acute Tonsillitis | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1036 | Acute Tonsillitis | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1058 | Upper Respiratory Infection | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1059 | Upper Respiratory Infection | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1066 | Comorbid Conditions for Respiratory Conditions | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.11.1067 | Comorbid Conditions for Respiratory Conditions | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.12.1011 | Acute Pharyngitis | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.12.1012 | Acute Tonsillitis | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.12.1017 | Competing Conditions for Respiratory Conditions | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.12.1022 | Upper Respiratory Infection | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.102.12.1025 | Comorbid Conditions for Respiratory Conditions | active | 2022-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1021 | Amenorrhea | active | 2022-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1022 | Amenorrhea | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1025 | Bilateral Oophorectomy | active | 2021-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1026 | Unilateral Oophorectomy Left | active | 2021-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1028 | Unilateral Oophorectomy Left | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1029 | Unilateral Oophorectomy Left | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.103.12.1001 | Diabetes | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.103.12.1020 | Type 1 Diabetes | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1030 | Unilateral Oophorectomy Right | active | 2021-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1031 | Unilateral Oophorectomy Right | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1032 | Unilateral Oophorectomy Right | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1034 | Unilateral Oophorectomy, Unspecified Laterality | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1035 | Unilateral Oophorectomy, Unspecified Laterality | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1036 | Eating Disorders | active | 2021-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1038 | Eating Disorders | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1039 | Eating Disorders | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.104.11.1029 | Essential Hypertension | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.104.11.1031 | Essential Hypertension | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.104.12.1011 | Essential Hypertension | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1040 | Major Transplant | active | 2021-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1042 | Major Transplant | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1043 | Potentially Harmful Antihistamines for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1046 | Evidence of Bilateral Oophorectomy | active | 2021-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1048 | Evidence of Bilateral Oophorectomy | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1049 | Potentially Harmful Antiparkinsonian Agents for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1010 | Mental Health Diagnoses | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1012 | Mental Health Diagnoses | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1017 | Major Depression | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1019 | Major Depression | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1060 | Major Depression In Remission | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1062 | Major Depression In Remission | active | 2025-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1161 | Schizophrenia or Psychotic Disorder | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1162 | Schizophrenia or Psychotic Disorder | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1163 | Schizophrenia or Psychotic Disorder | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1206 | Mental Behavioral and Neurodevelopmental Disorders | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1207 | Mental Behavioral and Neurodevelopmental Disorders | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1210 | Schizophrenia | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1211 | Schizophrenia | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1212 | Seizure Disorder | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1213 | Seizure Disorder | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1214 | REM | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1215 | REM | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1216 | Benzodiazepine Withdrawal | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1217 | Benzodiazepine Withdrawal | active | 2025-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1218 | Alcohol Withdrawal | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1219 | Alcohol Withdrawal | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1220 | General Anxiety | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1221 | General Anxiety | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1004 | Mental Health Diagnoses | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1007 | Major Depression | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1104 | Schizophrenia or Psychotic Disorder | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1203 | Mental Behavioral and Neurodevelopmental Disorders | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1205 | Schizophrenia | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1206 | Seizure Disorder | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1207 | REM Sleep Behavior Disorder | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1208 | Benzodiazepine Withdrawal | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1209 | Alcohol Withdrawal | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1210 | Generalized Anxiety Disorder | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1050 | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1051 | Dipyridamole Medications | active | 2021-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1053 | Nifedipine Medications | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1054 | Potentially Harmful Antidepressants for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1055 | Potentially Harmful Barbiturates for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1057 | Meprobamate Medications | active | 2021-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1058 | Potentially Harmful Estrogens for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1059 | Potentially Harmful Sulfonylureas for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1001 | Substance Use Disorder | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1003 | Substance Use Disorder | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1012 | Substance Use Disorder Treatment | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1036 | Substance Use Disorder Treatment | active | 2021-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.12.1001 | Substance Use Disorder | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.12.1005 | Substance Use Disorder Treatment | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1060 | Desiccated Thyroid Medications | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1062 | Potentially Harmful Skeletal Muscle Relaxants for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1063 | Potentially Harmful Pain Medications for Older Adults | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1065 | Digoxin Medications | active | 2021-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1066 | Digoxin Medications | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1067 | Doxepin Medications | active | 2021-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1068 | Doxepin Medications | active | 2021-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1001 | Malignant Neoplasm of Colon | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1003 | Malignant Neoplasm of Colon | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1025 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1027 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1044 | Pap Test | active | 2017-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1047 | Mammography | active | 2024-11 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1051 | Colonoscopy | active | 2023-11 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1052 | Colonoscopy | active | 2017-12 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1053 | Colonoscopy | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1145 | sDNA FIT Test | active | 2017-12 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1001 | Malignant Neoplasm of Colon | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1009 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1017 | Pap Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1018 | Mammography | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1020 | Colonoscopy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1038 | CT Colonography | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1039 | sDNA FIT Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1024 | Kidney Transplant | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1025 | Kidney Transplant | active | 2021-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1026 | Dialysis Services | active | 2021-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1027 | Dialysis Services | active | 2021-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1028 | Dialysis Services | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1029 | ESRD Monthly Outpatient Services | active | 2017-08 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1052 | Kidney Transplant | active | 2017-05 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1060 | Kidney Transplant Recipient | active | 2019-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1067 | Kidney Transplant | active | 2019-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1012 | Kidney Transplant | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1013 | Dialysis Services | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1014 | ESRD Monthly Outpatient Services | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1029 | Kidney Transplant Recipient | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1065 | DTaP Vaccine Administered | active | 2021-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1066 | DTaP Vaccine Administered | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1068 | Hepatitis A | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1070 | Hepatitis A | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1078 | Measles | active | 2021-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1080 | Measles | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1085 | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1086 | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1087 | Mumps | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1089 | Mumps | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1098 | Rubella | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.110 | Rubella | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1104 | Varicella Zoster | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1105 | Varicella Zoster | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1106 | Varicella Zoster Vaccine (VZV) Administered | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1107 | Varicella Zoster Vaccine (VZV) Administered | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1109 | Hepatitis A Vaccine Administered | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1110 | Hepatitis A Vaccine Administered | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1111 | Hepatitis B Vaccine Administered | active | 2021-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1112 | Hepatitis B Vaccine Administered | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1115 | Child Influenza Vaccine Administered | active | 2023-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1116 | Child Influenza Vaccine Administered | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1117 | Inactivated Polio Vaccine (IPV) Administered | active | 2021-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1118 | Inactivated Polio Vaccine (IPV) Administered | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1119 | Pneumococcal Conjugate Vaccine Administered | active | 2023-11 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1120 | Rotavirus Vaccine (3 dose schedule) Administered | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1121 | Rotavirus Vaccine (2 dose schedule) Administered | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1123 | Genital Herpes | active | 2024-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1124 | Genital Herpes | active | 2024-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1128 | Lab Tests for Sexually Transmitted Infections | active | 2022-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1129 | Chlamydia Screening | active | 2024-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1133 | Pneumococcal Conjugate Vaccine Administered | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1135 | HPV Test | active | 2024-11 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1148 | Rotavirus Vaccine (2 Dose Schedule) Administered | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1149 | Rotavirus Vaccine (3 Dose Schedule) Administered | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1150 | Advanced Illness | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1151 | Advanced Illness | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1152 | HiB Vaccine (3 dose schedule) | active | 2021-12 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1153 | HiB Vaccine (3 dose schedule) Administered | active | 2021-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1154 | HiB Vaccine (4 dose schedule) | active | 2021-09 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1155 | HiB Vaccine (4 dose schedule) Administered | active | 2021-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1156 | HiB Vaccine (3 dose schedule) Administered | active | 2024-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1157 | HiB Vaccine (4 dose schedule) Administered | active | 2024-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1158 | Competing Conditions for Respiratory Conditions | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1159 | Competing Conditions for Respiratory Conditions | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1022 | DTaP Vaccine Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1024 | Hepatitis A | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1031 | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1032 | Mumps | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1037 | Rubella | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1039 | Varicella Zoster | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1040 | Varicella Zoster Vaccine (VZV) Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1041 | Hepatitis A Vaccine Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1042 | Hepatitis B Vaccine Administered | active | 2022-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1044 | Child Influenza Vaccine Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1045 | Inactivated Polio Vaccine (IPV) Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1046 | Pneumococcal Conjugate Vaccine Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1047 | Rotavirus Vaccine (3 dose schedule) Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1048 | Rotavirus Vaccine (2 dose schedule) Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1049 | Genital Herpes | active | 2018-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1051 | Lab Tests for Sexually Transmitted Infections | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1052 | Chlamydia Screening | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1053 | Measles | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1059 | HPV Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1082 | Advanced Illness | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1083 | Hib Vaccine (3 dose schedule) | active | 2019-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1084 | Hib Vaccine (3 dose schedule) Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1085 | Hib Vaccine (4 dose schedule) | active | 2019-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1086 | Hib Vaccine (4 dose schedule) Administered | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1087 | Influenza Virus LAIV Vaccine | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1088 | Influenza Virus LAIV Vaccine Administered | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1012 | Lab Tests During Pregnancy | active | 2023-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1013 | Diagnostic Studies During Pregnancy | active | 2022-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1019 | Pregnancy Test | active | 2023-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1022 | Complications of Pregnancy, Childbirth and the Puerperium | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1023 | Complications of Pregnancy, Childbirth and the Puerperium | active | 2023-02 | us | hl7 | sct |